-+ 0.00%
-+ 0.00%
-+ 0.00%

Palvella Therapeutics Chief Operating Officer Kathleen Goin Reports Sale of $537,307.388 in Common Shares

PUBT·10/23/2026 20:06:34
Listen to the news
Palvella Therapeutics Chief Operating Officer Kathleen Goin Reports Sale of $537,307.388 in Common Shares
  • Palvella Therapeutics Chief Operating Officer Kathleen Goin sold 4,313 common shares on Oct. 21, 2026.
  • Goin exercised stock options for 2,165 shares at $7.14 per share and 2,148 shares at $9.08 per share.
  • Sales comprised 2,043 shares at $123.6214, 1,663 at $125.1645 and 607 at $126.1949 per share.
  • Her directly owned common stock holdings fell to zero following the transactions, according to the Form 4 filed Oct. 23, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-118466), on October 23, 2026, and is solely responsible for the information contained therein.